MEG
GSK icon

Millstone Evans Group’s GSK GSK Stock Holding History

Millstone Evans Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Hold
487
– – 0.01% 467
2026
Q1 		$26.9K Hold
487
– – 0.02% 442
2025
Q4 		$23.9K Buy
487
+184
+61% +$8.58K 0.01% 450
2025
Q3 		$13.1K Hold
303
– – 0.01% 502
2025
Q2 		$11.6K Hold
303
– – 0.01% 509
2025
Q1 		$11.7K Hold
303
– – 0.01% 509
2024
Q4 		$10.2K Buy
+303
New +$10.9K 0.01% 492

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Millstone Evans Group's GSK Position: Q2 2026 in Review

Millstone Evans Group held its GSK (GSK) position steady in Q2 2026 at 487 shares worth $25.5K. The position accounts for 0.01% of the portfolio, ranked #467.

Millstone Evans Group first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.9K in Q1 2026. 882 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Millstone Evans Group held 487 shares of GSK worth $25.5K as of Q2 2026.
  • Millstone Evans Group left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #467 holding.
  • Millstone Evans Group first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's GSK position peaked at $26.9K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.